Home » Topics » BioWorld Science

BioWorld Science
RSS

Class III antiarrhythmic presented by Japanese academics

April 26, 1996

GP-531 enters phase II

April 26, 1996

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

BMS-191095 in phase I for ischemia

April 26, 1996

Kanebo reveals new Na+/Ca2+ exchange inhibitor

April 26, 1996

FR-168888 shows myocardial protective effects in animals

April 26, 1996

Banyu's BR-1022 for angina

April 26, 1996

CP-060S suppresses myocardial cell calcium overload

April 26, 1996

Novel vasodilator MCC-134 reported by Mitsubishi Chemical

April 26, 1996

PC-286 lowers blood pressure in rats

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...